Sachdev Vandana, Machado Roberto F, Shizukuda Yukitaka, Rao Yesoda N, Sidenko Stanislav, Ernst Inez, St Peter Marilyn, Coles Wynona A, Rosing Douglas R, Blackwelder William C, Castro Oswaldo, Kato Gregory J, Gladwin Mark T
Cardiovascular Branch, Echocardiography Laboratory, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892-1454, USA.
J Am Coll Cardiol. 2007 Jan 30;49(4):472-9. doi: 10.1016/j.jacc.2006.09.038. Epub 2007 Jan 16.
The goal of this study was to characterize left ventricular diastolic function in the sickle cell disease (SCD) population and to relate echocardiographic measures of dysfunction with pulmonary hypertension and mortality.
Pulmonary hypertension has been identified as a predictor of death in the adult SCD population. Although diastolic dysfunction is also observed in this population, its prevalence, association with high pulmonary artery systolic pressure, and attributable mortality remain unknown.
Diastolic function assessment using tissue Doppler imaging was performed in a group of 141 SCD patients. Conventional echocardiographic parameters of diastolic function were performed in a total of 235 SCD patients.
Diastolic dysfunction was present in 18% of patients. A combination of diastolic dysfunction and pulmonary hypertension was present in 11% of patients, and diastolic dysfunction accounted for only 10% to 20% of the variability in tricuspid regurgitation (TR) jet velocity. Diastolic dysfunction, as reflected by a low E/A ratio, was associated with mortality with a risk ratio of 3.5 (95% confidence interval 1.5 to 8.4, p < 0.001), even after adjustment for tricuspid regurgitation (TR) jet velocity. The presence of both diastolic dysfunction and pulmonary hypertension conferred a risk ratio for death of 12.0 (95% confidence interval 3.8 to 38.1, p < 0.001).
Diastolic dysfunction and pulmonary hypertension each contribute independently to prospective mortality in patients with SCD. Patients with both risk factors have an extremely poor prognosis. These data support the implementation of echocardiographic screening of adult patients with SCD to identify high-risk individuals for further evaluation.
本研究的目的是描述镰状细胞病(SCD)人群的左心室舒张功能,并将功能障碍的超声心动图测量结果与肺动脉高压和死亡率相关联。
肺动脉高压已被确定为成人SCD人群死亡的预测指标。尽管在该人群中也观察到舒张功能障碍,但其患病率、与肺动脉收缩压升高的关联以及可归因的死亡率仍不清楚。
对一组141例SCD患者进行组织多普勒成像舒张功能评估。对总共235例SCD患者进行了舒张功能的传统超声心动图参数测量。
18%的患者存在舒张功能障碍。11%的患者同时存在舒张功能障碍和肺动脉高压,舒张功能障碍仅占三尖瓣反流(TR)射流速度变异性的10%至20%。低E/A比值反映的舒张功能障碍与死亡率相关,风险比为3.5(95%置信区间1.5至8.4,p<0.001),即使在调整三尖瓣反流(TR)射流速度后也是如此。舒张功能障碍和肺动脉高压同时存在时,死亡风险比为12.0(95%置信区间3.8至38.1,p<0.001)。
舒张功能障碍和肺动脉高压各自独立地导致SCD患者的预期死亡率。同时具有这两种危险因素的患者预后极差。这些数据支持对成年SCD患者进行超声心动图筛查,以识别高危个体进行进一步评估。